Dave Marver is an accomplished chief executive with a broad range of experience gained leading public, private, and emerging companies in the US and Europe. He has sector expertise in medical technology, wearables, consumer technology, and health monitoring. He is also an experienced Board member with multiple successful exits under his governance.
Dave spent almost 15 years with Medtronic in a variety of leadership positions around the world. Representative roles included VP Sales for Medtronic’s Cardiac Surgery business, VP Marketing and interim Business Unit Leader for Medtronic’s CRM business in Europe, and VP Strategy for Medtronic’s Diabetes business. Later, Dave served as CEO for Cardiac Science Corporation, a NASDAQ-listed company with 600 employees that was #2 in the world in AEDs and #1 in the US in stress test treadmills. He then founded and ran a high-profile sports technology start-up, raising $90M and developing two TIME Magazine Inventions of the Year. Dave corporate Board experience includes Cirtec Medical Systems, (acquired by 3i Group), JointMetrix Medical (acquired by Zimmer), Cardiac Science (acquired by Opto Circuits), PreciSense A/S (acquired by Medtronic), and Precision Wire Components (acquired by Riverside Partners).
Dave has been an advisor to the World Bank’s International Finance Group and a member of the Health Industry Distributors Association Board of Directors and Duke University’s Health Sector Advisory Council. He has guest lectured at the graduate business schools for Duke University, University of Washington, and University of California at Los Angeles. Dave earned a BA from Duke University and an MBA from University of California at Los Angeles.